ReviewDrug design, development and therapy2017

Clinical and pharmacological hallmarks of rifapentine's use in diabetes patients with active and latent tuberculosis: do we know enough?

Chunlan Zheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.